Cited by 557CRISPR and Genetic EngineeringAcute Myeloid Leukemia ResearchChromatin Remodeling and Cancer

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing

Open access

Heckl, Dirk, Kowalczyk, Monika S, Yudovich, David, Belizaire, Roger, Puram, Rishi V, McConkey, Marie E, Thielke, Anne, Aster, Jon C, Regev, Aviv, Ebert, Benjamin L·2014·Nature Biotechnology

DOI 10.1038/nbt.2951PMC PMC4160386

Open this paper in CoChat — free account

Abstract

Genome sequencing studies have shown that human malignancies often bear mutations in four or more driver genes, but it is difficult to recapitulate this degree of genetic complexity in mouse models using conventional breeding. Here we use the CRISPR-Cas9 system of genome editing to overcome this limitation. By delivering combinations of small guide RNAs (sgRNAs) and Cas9 with a lentiviral vector, we modified up to five genes in a single mouse hematopoietic stem cell (HSC), leading to clonal outgrowth and myeloid malignancy. We thereby generated models of acute myeloid leukemia (AML) with cooperating mutations in genes encoding epigenetic modifiers, transcription factors and mediators of cytokine signaling, recapitulating the combinations of mutations observed in patients. Our results suggest that lentivirus-delivered sgRNA:Cas9 genome editing should be useful to engineer a broad array of in vivo cancer models that better reflect the complexity of human disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.2951

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citation
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856

Show all 27 references

Sorted by citations

Items 501–557 of 557

Chromatin-based techniques map DNA interaction landscapes in psoriasis susceptibility loci and highlight KLF4 as a target gene in 9q31Preprint
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/822304
Genetically Engineered Mouse Models for Studying Radiation Biology and Radiosensitizers
Floyd, W., Kuo, H.-C., Himes, J. E., Patel, R., & Kirsch, D. G. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_8
The ethics of gene editing in human stem cells
Tezel, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817876-8.00005-x
Distinct and interchangeable growing patterns in colorectal cancer stem-like cells are regulated by Musashi-1Preprint
Coppo, R., Kondo, J., Iida, K., Okada, M., Onuma, K., Tanaka, Y., Kamada, M., Ohue, M., Kawada, K., Obama, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.25.469977
Genome Editing in Cellular Disease Models
Theurey, P., Thiam, K., Chérifi, Y., Fraichard, A., & Rezza, A. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch6
Faculty Opinions recommendation of The Dynamic Landscape of Open Chromatin during Human Cortical Neurogenesis.
Borrell, V. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732397732.793566104
Faculty Opinions recommendation of Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance.
Stein, J. V., & Altenburger, L. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737458383.793573680
Precise modelling and correction of a spectrum of β-thalassemic mutations in human erythroid cells by base editorsPreprint
Prasad, K. M., Devaraju, N., George, A., Ravi, N. S., Mahalingam, G., Rajendiran, V., Panigrahi, L., Venkatesan, V., Lakhotiya, K., Moorthy, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.01.494256
PRC2 Inactivating Mutations in Cancer are Synthetic Lethal with DNMT1 Targeted Therapy via Enhanced Viral MimicryPreprint
Patel, A. J., Warda, S., Mååg, J. L. V., Misra, R., Miranda-Román, M. A., Pachai, M. R., Li, D., Wang, N., Lee, C. J., Bayshtok, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.28.493429
Hyperactive NK cells in Rag2 knockout mice inhibit the development of acute myeloid leukemiaPreprint
Sugimoto, E., Hayashi, Y., Iida, K., Asada, S., Fukushima, T., Tamura, M., Kawabata, K. C., Kawase, T., Saito, T., Yoshida, T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1934697/v1
Bioreactor-Based Tissue Models as an Alternative Approach in Cancer Research
Bişgin, A., & Mujde, C. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_12-1
A A Review on the Potential of Application of CRISPR/Cas9 Technology in CYP3A4 and CYP2D6 Genes: A Way to Move Forward in Identifying New Drug Targets
Hatta, F. H. M., Othman, A. A., Yusoff, R. M., Azam, S. N. N., & Hassan, A. Z. A. (2022) · ASM Science Journal · doi:10.32802/asmscj.2022.999
Bioreactor-Based Tissue Models as an Alternative Approach in Cancer Research
Bişgin, A., & Mujde, C. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_12
Data from Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing
Sayed, S., Sidorova, O. A., Hennig, A., Augsburg, M., Vesga, C. P. C., Abohawya, M., Schmitt, L. T., Sürün, D., Stange, D. E., Mircetic, J., et al. (2023) · doi:10.1158/0008-5472.c.6514029.v1
Supplementary Methods, Figures 1 - 14, Tables 1 - 5 from Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia
Kühn, M. W. M., Song, E., Feng, Z., Sinha, A., Chen, C.-W. D., Deshpande, A. J., Cusan, M., Farnoud, N. R., Mupo, A., Grove, C. S., et al. (2023) · doi:10.1158/2159-8290.22531056
CRISPR/Cas9’s Major Role in Revolutionizing the Field of Cancer
Singh, A., Sharma, K., Abdulbaseer, U., Lopez, E. L., & Sharma, A. (2023) · Current Cancer Therapy Reviews · doi:10.2174/1573394719666230426152155
The CRISPR/Cas System in Human Cancer
Bonamino, M., & Correia, E. M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-33325-5_4
Advantages and Challenges of CRISPR-Cas9 Applications in Animal Modeling: A Concise Review CRISPR-Cas9 Applications in Animal Modeling
Ghasemian, A., Nournia, E., Nikfar, G., Kohansal, M., Mohammad, G., Salahi, A., & Memariani, M. (2023) · Journal of Advanced Biomedical Sciences · doi:10.18502/jabs.v13i4.13897
Additional file 5 of High throughput single-cell detection of multiplex CRISPR-edited gene modifications
ten Hacken, E., Clement, K., Li, S., Hernández‐Sánchez, M., Redd, R. A., Wang, S., Ruff, D., Gruber, M., Baranowski, K., Jacob, J. P., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13120623
Additional file 6 of High throughput single-cell detection of multiplex CRISPR-edited gene modifications
ten Hacken, E., Clement, K., Li, S., Hernández‐Sánchez, M., Redd, R. A., Wang, S., Ruff, D., Gruber, M., Baranowski, K., Jacob, J. P., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13120626
Additional file 4 of High throughput single-cell detection of multiplex CRISPR-edited gene modifications
ten Hacken, E., Clement, K., Li, S., Hernández‐Sánchez, M., Redd, R. A., Wang, S., Ruff, D., Gruber, M., Baranowski, K., Jacob, J. P., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13120620
Additional file 3 of High throughput single-cell detection of multiplex CRISPR-edited gene modifications
ten Hacken, E., Clement, K., Li, S., Hernández‐Sánchez, M., Redd, R. A., Wang, S. F., Ruff, D., Gruber, M., Baranowski, K., Jacob, J. P., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13120617
Additional file 2 of High throughput single-cell detection of multiplex CRISPR-edited gene modifications
ten Hacken, E., Clement, K., Li, S., Hernández‐Sánchez, M., Redd, R. A., Wang, S., Ruff, D., Gruber, M., Baranowski, K., Jacob, J. P., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13120611
Aplicaciones clínicas de la herramienta CRISPR-Cas
Vaglio-Cedeño, C., Rodriguez, E. J. R., & Morales, F. (2023) · Acta Médica Costarricense · doi:10.51481/amc.v65i3.1268
Interferon regulatory factor 4 modulates epigenetic silencing and cancer‐critical pathways in melanoma cells
Sobhiafshar, U., Çakici, B., Yilmaz, E., Ayhan, N. Y., Hedaya, L., Ayhan, M. C., Yerinde, C., Alankus, Y. B., Gürkaşlar, H. K., Firat‐Karalar, E. N., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13672 · Cited by 1
Dual MYC and GSPT1 Protein Degrader for MYC-Driven CancersPreprint
Nishida, Y., Impedovo, V., Ayoub, E., Baran, N., Scruggs, D. A., Mizuno, H., Khazaei, S., Ostermann, L. B., Singh, S., Bedoy, A. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.24.650490
Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Wang, Y., Hu, J., & Zhang, J. (2025) · Journal of Visualized Experiments · doi:10.3791/67508
Advancement of CRISPR/Cas9 in Translational Biomedicines
Atale, N., Kong, Q., & Rani, V. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80973-6_5
Additional file 10 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246839
Additional file 4 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246902
Additional file 8 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246926
Additional file 14 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246872
Additional file 1 of The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma
Ren, Z., Lantermans, H. C., Kuil, A., Kraan, W., Arenzana‐Seisdedos, F., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2021) · Figshare · doi:10.6084/m9.figshare.13566005
Additional file 6 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246908
Additional file 13 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246866
Additional file 11 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246851
Additional file 1 of Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin
Šimčíková, D., Gardáš, D., Hložková, K., Hruda, M., Žáček, P., Rob, L., & Heneberg, P. (2021) · Figshare · doi:10.6084/m9.figshare.17163368
Additional file 7 of High throughput single-cell detection of multiplex CRISPR-edited gene modifications
ten Hacken, E., Clement, K., Li, S., Hernández-Sánchez, M., Redd, R. A., Wang, S., Ruff, D., Gruber, M., Baranowski, K., Jacob, J. P., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13120629
Additional file 9 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246932
Additional file 1 of High throughput single-cell detection of multiplex CRISPR-edited gene modifications
ten Hacken, E., Clement, K., Li, S., Hernández-Sánchez, M., Redd, R. A., Wang, S., Ruff, D., Gruber, M., Baranowski, K., Jacob, J. P., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13120605
Additional file 2 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246887
Additional file 3 of Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
Ray-Jones, H. F., Duffus, K., McGovern, A., Martin, P., Shi, C., Hankinson, J., Gough, O., Yarwood, A., Morris, A. P., Adamson, A. D., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12246896
A commensally regulated immune rheostat fine-tunes skin barrier fitness
Gola, A., Srinivas, R., Rodig, E. G., Schernthanner, M., Abdusselamoglu, M. D., Tierney, M. T., Alexander, N. J., Gonzales, K. A. U., Sajjath, S. M., Soto-Ugaldi, L. F., et al. (2026) · Science · doi:10.64898/2026.01.07.698149
Impact des mutations d'un modificateur chromatinien dans le développement du cervelet et le médulloblastome de groupe Sonic Hedgehog
Mercier, A. L. (2018) · theses.fr (ABES) · doi:10.70675/cf8ed0a3z6564z4b11zb37azce37ce215cf7
Molecular characterization and functional analysis of poor-prognosis B-cell leukemias
Bougacha, N. (2019) · theses.fr (ABES) · doi:10.70675/86f73dd3z982dz4a64z9670zd4291a5714a3
A Pleiotropic Role of the SWI/SNF Complex in Cancer – Insights From Two Tumor Types : Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Prostatic Carcinoma
Cyrta, J. (2020) · theses.fr (ABES) · doi:10.70675/cf34a9efze9e1z4314z8adczf59479f94559
Mécanismes moléculaires impliquant JAM-C dans le maintien du caractère souche des cellules de leucémies aigües myéloïdes
Grenier, J. M. P. (2021) · theses.fr (ABES) · doi:10.70675/1aab1369zd34cz4476z8c46z39a2c3df85b6
Factors That Affect Chromosomal Translocations in Cells
Canoy, R. J. (2021) · theses.fr (ABES) · doi:10.70675/9f331f7az9151z4c95zbf47zbc6ed65a5896
Études de l’impact des anomalies génétiques dans l’initiation, l’évolution et la résistance au traitement dans la leucémie lymphoïde chronique : exemple de la mutation d’IKZF3 p.L162R et des anomalies de TP53
Lazarian, G. (2020) · theses.fr (ABES) · doi:10.70675/7f636de6zaf02z4ea6z9684ze5e5ae32ab78
Oncogénèse des proliférations de cellules dendritiques plasmocytoïdes associées aux leucémies aiguës myéloïdes et études des interactions au sein du microenvironnement leucémique
Roussel, X. (2024) · theses.fr (ABES) · doi:10.70675/86be6d90zdcaez4a72z9eb7z6662afeed2f5
Multiplex genome engineering: Methodologies and applications
Peng, S., Xie, W., Zhu, J., & Bao, Z. (2026) · Cell Systems · doi:10.1016/j.cels.2026.101614 · Cited by 1
Deletion of the MALAT1 RNA 3’ end Promotes Transcript Decay and Inhibits Proliferation in Gastric and Breast Cancer CellsPreprint
Cortes-Arias, A., Valdes, V., Muñoz-González, M., Leiva, D., Acevedo, A., Tobar-Lara, M., Farfán, N., Oni, L., Quiñones‐Medina, E., Burzio, V. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726613
Deletion of the MALAT1 RNA 3’ end promotes transcript decay and inhibits proliferation in gastric and breast cancer cells
Cortes-Arias, A., Valdes, V., Muñoz-González, M., Leiva, D., Acevedo, A., Tobar-Lara, M., Farfán, N., Oni, L., Quiñones‐Medina, E., Burzio, V. A., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154181
Genetic Engineering of Natural Killer Cells: Unleashing Their Killer Instincts
Kluge, P., Lai, K.-Y., Knapp, L. R., Sapre, A., Tarannum, M., Raskó, T., Romee, R., Bexte, T., & Ullrich, E. (2026) · Springer eBooks · doi:10.1007/978-3-662-68816-8_48-1
NUDT2 loss defines quantitative limits for dinucleoside polyphosphate action on the cGAS–STING–TBK1 axisPreprint
Weiland, P. S., Shivakumar, R. D., Jalomo-Khayrova, E., Schmidt, J., Zegarra, V., Wang, Y., Paczia, N., Kiontke, S., Burchert, A., & Bange, G. (2026) · eLife · doi:10.7554/elife.112828
NUDT2 loss defines quantitative limits for dinucleoside polyphosphate action on the cGAS–STING–TBK1 axisPreprint
Weiland, P. S., Shivakumar, R. D., Jalomo-Khayrova, E., Schmidt, J., Zegarra, V., Wang, Y., Paczia, N., Kiontke, S., Burchert, A., & Bange, G. (2026) · eLife · doi:10.7554/elife.112828.1
PLA2G6 in attenuating ferroptosis
Sadovsky, Y. (2020) · ImmPort · doi:10.21430/m3kaq17awd

Authors: Heckl, D., Kowalczyk, M. S., Yudovich, D., Belizaire, R., Puram, R. V., McConkey, M. E., Thielke, A., Aster, J. C., Regev, A., & Ebert, B. L.
Affiliations: Brigham and Women's Hospital (US)
Broad Institute (US)
Corresponding author: Ebert, Benjamin L
ORCID: Heckl, Dirk
Kowalczyk, Monika S
Yudovich, David
Belizaire, Roger
McConkey, Marie E
Aster, Jon C
Regev, Aviv
Ebert, Benjamin L
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2014-06-22
Volume: 32
Issue: 9
Pages: 941-946
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.2951
PMC: PMC4160386
OpenAlex: W1575193685
Cited by: 555
References: 27
Citations by year: 2026: 14 · 2025: 29 · 2024: 28 · 2023: 58 · 2022: 58 · 2021: 58 · 2020: 61 · 2019: 51 · 2018: 54 · 2017: 61 · 2016: 38 · 2015: 39 · 2014: 5
FWCI: 19.53
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
Funders: National Heart, Lung, and Blood Institute (R01HL082945)
National Human Genome Research Institute (P50HG006193)
National Cancer Institute (P01CA108631, P01CA066996)
National Institute of General Medical Sciences (T32GM007753)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: myeloid neoplasms, acute myeloid leukemia, mouse tumor model, CRISPR/Cas9 genome editing, lentiviral delivery, hematopoietic stem cells, clonal outgrowth, driver mutations, epigenetic regulators, transcription factors, cytokine signaling, cooperating mutations
MeSH terms: Animals, Disease Models, Animal, Bone Marrow Neoplasms, Mice, Clustered Regularly Interspaced Short Palindromic Repeats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks